BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24463134)

  • 1. [Pro-apoptosis and selective anticancer activities of prostate apoptosis response protein 4: research progress and prospects].
    Wu Z; Wang G; Zhang K
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):128-32. PubMed ID: 24463134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cancer cell survival by Par-4.
    Ranganathan P; Rangnekar VM
    Ann N Y Acad Sci; 2005 Nov; 1059():76-85. PubMed ID: 16382046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.
    Gurumurthy S; Goswami A; Vasudevan KM; Rangnekar VM
    Mol Cell Biol; 2005 Feb; 25(3):1146-61. PubMed ID: 15657440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-selective apoptosis by tumor suppressor par-4.
    Hebbar N; Shrestha-Bhattarai T; Rangnekar VM
    Adv Exp Med Biol; 2014; 818():155-66. PubMed ID: 25001535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
    Vetterkind S; Boosen M; Scheidtmann KH; Preuss U
    Int J Oncol; 2005 Jan; 26(1):159-67. PubMed ID: 15586236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
    Kline CL; Irby RB
    Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
    J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells.
    Casolari DA; Pereira MC; de Bessa Garcia SA; Nagai MA
    Int J Mol Med; 2011 Sep; 28(3):337-42. PubMed ID: 21567071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Par-4 inhibits non-autochthonous tumor growth.
    Zhao Y; Burikhanov R; Brandon J; Qiu S; Shelton BJ; Spear B; Bondada S; Bryson S; Rangnekar VM
    Cancer Biol Ther; 2011 Jul; 12(2):152-7. PubMed ID: 21613819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.
    Srinivasan S; Ranga RS; Burikhanov R; Han SS; Chendil D
    Cancer Res; 2007 Jan; 67(1):246-53. PubMed ID: 17185378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Par-4 inducible apoptosis in prostate cancer cells.
    Gurumurthy S; Rangnekar VM
    J Cell Biochem; 2004 Feb; 91(3):504-12. PubMed ID: 14755681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of prostate apoptosis response (Par-4) is associated with progesterone receptor in breast cancer.
    Zapata-Benavides P; Méndez-Vázquez JL; González-Rocha TR; Zamora-Avila DE; Franco-Molina MA; Garza-Garza R; Rodriguez-Padilla C
    Arch Med Res; 2009 Oct; 40(7):595-9. PubMed ID: 20082875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory expression of Par-4 SAC-HA2TAT following adeno-associated virus-mediated gene transfer induces apoptosis in HepG2 cells.
    Qin TJ; Ma W; Liu SX; Yang GX; Wang QY; Zhao XH
    Mol Med Rep; 2010; 3(5):749-57. PubMed ID: 21472309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Par-4 as a potential target for cancer therapy.
    Irby RB; Kline CL
    Expert Opin Ther Targets; 2013 Jan; 17(1):77-87. PubMed ID: 23062118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-selective apoptotic effects of extracellular and intracellular Par-4.
    Shrestha-Bhattarai T; Rangnekar VM
    Oncogene; 2010 Jul; 29(27):3873-80. PubMed ID: 20440265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
    Kukoc-Zivojnov N; Puccetti E; Chow KU; Bergmann M; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Boehrer S
    Exp Hematol; 2004 Jul; 32(7):649-56. PubMed ID: 15246161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines.
    Lee JW; Lee KF; Hsu HY; Hsu LP; Shih WL; Chu YC; Hsiao WT; Liu PF
    Cancer Lett; 2007 Nov; 257(2):252-62. PubMed ID: 17881119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells.
    Lee TJ; Lee JT; Kim SH; Choi YH; Song KS; Park JW; Kwon TK
    J Cell Biochem; 2008 Feb; 103(2):358-68. PubMed ID: 18041764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Par-4-mediated recruitment of Amida to the actin cytoskeleton leads to the induction of apoptosis.
    Boosen M; Vetterkind S; Koplin A; Illenberger S; Preuss U
    Exp Cell Res; 2005 Dec; 311(2):177-91. PubMed ID: 16229834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the expression of prostate apoptosis response protein 4 (Par-4) in rat granulosa cells.
    Gonzalez IH; Santana P; Gonzalez-Robayna I; Ferrer M; Morales V; Blanco FL; Fanjul LF
    Apoptosis; 2007 Apr; 12(4):769-79. PubMed ID: 17219052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.